Scilex Holding (SCLXW) Capital Expenditures (2022 - 2026)

Scilex Holding (SCLXW) recorded quarterly Capital Expenditures of $200000.0 in Q1 2026, up 19900.0% quarter-over-quarter from $1000.0 in Q4 2023.

Scilex Holding (SCLXW) Capital Expenditures (2022 - 2026) Analysis & Trends

Scilex Holding's Capital Expenditures history runs 3 years deep, the most recent figure standing at $200000.0 for Q1 2026.

  • In Q1 2026, Capital Expenditures changed N/A year-over-year to $200000.0; the TTM figure through Mar 2026 stood at $200000.0 (up 19900.0% YoY), while the FY2025 annual figure was $133000.0, changed N/A from the prior year.
  • Capital Expenditures was $200000.0 for Q1 2026 at Scilex Holding, up from $1000.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $200000.0 in Q1 2026 to a low of $1000.0 in Q4 2023.
  • Historically, Capital Expenditures has averaged $57250.0 across 3 years, with a median of $14000.0 in 2022.
  • Biggest YoY gain for Capital Expenditures was 200.0% in 2023; the steepest drop was 200.0% in 2023.
  • A 3-year view of Capital Expenditures shows it stood at $7000.0 in 2022, then slumped by 85.71% to $1000.0 in 2023, then jumped by 19900.0% to $200000.0 in 2026.
  • The last three Capital Expenditures figures came in at $200000.0 (Q1 2026), $1000.0 (Q4 2023), and $21000.0 (Q3 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn -297.95 Mn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn 2.33 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 1.05 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn 265.00 Mn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn 991.00 Mn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 712.00 Mn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 117.00 Mn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn 436.00 Mn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn 347.00 Mn
10 Scilex Holding - - 4.15 Mn 200,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 200,000.00
Mar 31, 2026 200,000.00
Dec 31, 2023 1,000.00
Dec 31, 2023 1,000.00
Sep 30, 2023 21,000.00
Sep 30, 2023 21,000.00
Sep 30, 2022 7,000.00
Sep 30, 2022 7,000.00